Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Martinoli

Showing results (121-130 of 129) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 129 results.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|February 6, 2013
Ultrasound as a useful tool in the diagnosis and management of traumatic nerve lesionsL Padua, A Di Pasquale, G Liotta, et al.
Kidney International. Supplement|January 4, 1998
Microalbuminuria: a marker of cardiovascular risk and organ damage in essential hypertensionR Pontremoli, F Viazzi, A Sofia, et al.
American Journal of Hypertension|June 2, 1998
Microalbuminuria is an early marker of target organ damage in essential hypertensionR Pontremoli, C Nicolella, F Viazzi, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 2015
Personalised medicine: Development and external validation of a prognostic model for metastatic melanoma patients treated with ipilimumabS Valpione, C Martinoli, P Fava, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 9, 1999
Increased renal resistive index in patients with essential hypertension: a marker of target organ damageR Pontremoli, F Viazzi, C Martinoli, et al.
Ecancermedicalscience|March 17, 2016
Dabrafenib in metastatic melanoma: a monocentric 'real life' experienceE Cocorocchio, S Gandini, S Alfieri, et al.
British Journal of Cancer|May 27, 2015
Baseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated metastatic melanoma patientsP F Ferrucci, S Gandini, A Battaglia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2016
Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumabP F Ferrucci, P A Ascierto, J Pigozzo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 6, 2017
Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumabP F Ferrucci, P A Ascierto, J Pigozzo, et al.
Pageof 13

Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|February 6, 2013
Ultrasound as a useful tool in the diagnosis and management of traumatic nerve lesionsL Padua, A Di Pasquale, G Liotta, et al.
Kidney International. Supplement|January 4, 1998
Microalbuminuria: a marker of cardiovascular risk and organ damage in essential hypertensionR Pontremoli, F Viazzi, A Sofia, et al.
American Journal of Hypertension|June 2, 1998
Microalbuminuria is an early marker of target organ damage in essential hypertensionR Pontremoli, C Nicolella, F Viazzi, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 2015
Personalised medicine: Development and external validation of a prognostic model for metastatic melanoma patients treated with ipilimumabS Valpione, C Martinoli, P Fava, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 9, 1999
Increased renal resistive index in patients with essential hypertension: a marker of target organ damageR Pontremoli, F Viazzi, C Martinoli, et al.
Ecancermedicalscience|March 17, 2016
Dabrafenib in metastatic melanoma: a monocentric 'real life' experienceE Cocorocchio, S Gandini, S Alfieri, et al.
British Journal of Cancer|May 27, 2015
Baseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated metastatic melanoma patientsP F Ferrucci, S Gandini, A Battaglia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2016
Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumabP F Ferrucci, P A Ascierto, J Pigozzo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 6, 2017
Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumabP F Ferrucci, P A Ascierto, J Pigozzo, et al.
Pageof 13